GSK’s COVID-19 Antibody Treatment Approved in Japan

GSK’s COVID-19 Antibody Treatment Approved in Japan

GSK’s (GlaxoSmithKline) and Vir Biotechnology’s antibody treatment for COVID-19, Sotrovimab has been approved in Japan, Health Minister Norihisa Tamura announced this week. Aiming to treat mild to moderate coronavirus cases, GSK’s antibody treatment...